Changes in Hong Kong stocks | Minimally Invasive Robot-B (02252) rises another 10%, Tumai Robotics is accelerating the internationalization process, and institutions are optimistic about the recovery in procurement of some medical equipment products

The Zhitong Finance App learned that minimally invasive robot-B (02252) rose by more than 10% in early trading. As of press release, it had risen 4.17% to HK$9, with a turnover of HK$69.551 million.

According to the news, on January 16, at the Minimally Invasive Robotics Headquarters Surgical Robotics Global Remote Command Center, French surgeons used Tumai robots to perform remote surgery on patients as far away as Casablanca, Morocco. He Chao, president of Minimally Invasive Robotics Group, said that this is another major breakthrough after Tumai Robotics assisted domestic experts to complete remote surgery from Shanghai to Benin in October of this year. It marks that Tumai robots have entered the “1 to 10” stage of development, and the internationalization process will accelerate.

China Post Securities released a research report saying that in-hospital medical rectification has become normalized, and the impact on recruitment is weakening; approval of equipment trade-in policies is progressing steadily; and favorable factors such as the gradual implementation of ultra-long-term treasury bonds and interest-rate loans, the performance of in-hospital recruitment data is clearly improving. It is expected that starting in the fourth quarter of 2024, procurement for some medical equipment products will pick up rapidly, and procurement amounts in fields such as ultrasound, CT, MR, DR, endoscopy, and surgical robots will increase rapidly.